Hybrid Perventricular Venus P-Valve Implantation Via Mini-Thoracotomy in a Patient With Mechanical Tricuspid Valve Authors: Alper Guzeltas, Selman Gokalp, Sertac Haydin Published: 2026 ABSTRACT BackgroundChronic severe pulmonary regurgitation following repair of right ventricular outflow dysfunction may result in progressive right ventricular dilatation, heart failure, and arrhythmias. In patients with a complex surgical history, particularly those with mechanical tricuspid valve prostheses, standard transvenous access for pulmonary valve implantation can be technically challenging and carries risks for prosthetic valve injury.Case SummaryWe report a successful hybrid perventricular Venus P-Valve implantation via left mini-thoracotomy in a 29-year-old man with 2 prior cardiac surgeries, mechanical mitral and tricuspid valves. The procedure was performed on the beating heart without cardiopulmonary bypass, avoiding the risks of a third open-heart surgery.DiscussionThis case highlights the advantages of a hybrid perventricular pulmonary valve implantation strategy in patients with a mechanical tricuspid valve.Take-Home MessageHybrid perventricular access can expand transcatheter self-expanding pulmonary valve options in selected high-risk redo patients with a mechanical tricuspid valve and enlarged right ventricular outflow tract. Visual SummaryHybrid Perventricular Venus P-Valve Implantation via Mini-Thoracotomy in a High-Risk Redo Patient With a Mechanical Tricuspid ProsthesisASD = atrial septal defect; CPB = cardiopulmonary bypass; CTA = computed tomography angiography; RF = radiofrequency; RV = right ventricle; VSD = ventricular septal defect. Hybrid Perventricular Venus P-Valve Implantation via Mini-Thoracotomy in a High-Risk Redo Patient With a Mechanical Tricuspid Prosthesis ASD = atrial septal defect; CPB = cardiopulmonary bypass; CTA = computed tomography angiography; RF = radiofrequency; RV = right ventricle; VSD = ventricular septal defect. History of Presentation A 29-year-old patient presented with a gradually worsening exercise capacity over the past year. Physical examination revealed mechanical valve clicks and a grade 2/6 to-and-fro murmur at the left upper sternal border. Past Medical History The patient had a history of transitional atrioventricular septal defect and pulmonary stenosis, had undergone surgical closure of a primum atrial septal defect and ventricular septal defect, mitral cleft repair, and pulmonary valvotomy at 6 years of age. At 15 years of age, he required a second operation for mechanical mitral and tricuspid valve replacement (St Jude 27 and 31 mm, respectively; St Jude Medical). At 22 years of age, irrigated radiofrequency ablation was performed for intra-atrial reentrant tachycardia. Differential Diagnosis The patient's progressive exercise intolerance raised concern for severe pulmonary regurgitation (PR) with chronic right ventricular (RV) volume overload. Additional considerations included dysfunction of the mitral or tricuspid prostheses, atrial arrhythmia, worsening aortic regurgitation, and subaortic obstruction. Investigations Echocardiography demonstrated severe PR, with a color Doppler flow jet width/right ventricular outflow tract (RVOT) ratio >0.7 and diastolic flow reversal in branch pulmonary arteries (PAs), along with RV enlargement, normally functioning mechanical mitral and tricuspid prostheses, mild-to-moderate aortic regurgitation, and mild subaortic stenosis. Electrocardiography showed sinus rhythm with complete right bundle branch block and QRS duration of 140 ms. Cardiac magnetic resonance imaging (MRI) was not performed because the patient had severe claustrophobia and open MRI was not available at our institution; however, the patient was symptomatic and echocardiographic findings were consistent with severe PR. Despite the absence of MRI-derived RV volumetric data, these findings were considered sufficient to establish an indication for pulmonary valve replacement. Computed tomography angiography demonstrated a significantly dilated RV with hour-glass shape (Type V) and enlarged main PA displaying a folding at the sinotubular junction. Valvar-level perimeter-derived and surface area–derived diameters measured 29/29 mm in systole and 32/31 mm in diastole, whereas the distal main PA measured 30/29 mm in systole and 27/27 mm in diastole. The sinotubular junction measured perimeter-derived/surface area–derived diameters of 24/24 mm in systole and 22/22 mm in diastole, but this narrowing was considered potentially expandable during balloon testing rather than a fixed limiting segment (Figure 1).Figure 1Preprocedural CT Evaluation of the RVOT AnatomyTop: 3-dimensional CT reconstructions demonstrating RVOT and pulmonary artery morphology in right anterior oblique, left anterior oblique, and lateral projections. Bottom: Multiplanar CT images illustrating the dilated RVOT, pulmonary annulus, and narrowing at the sinotubular junction. CT = computed tomography; RVOT = right ventricular outflow tract. Preprocedural CT Evaluation of the RVOT Anatomy Top: 3-dimensional CT reconstructions demonstrating RVOT and pulmonary artery morphology in right anterior oblique, left anterior oblique, and lateral projections. Bottom: Multiplanar CT images illustrating the dilated RVOT, pulmonary annulus, and narrowing at the sinotubular junction. CT = computed tomography; RVOT = right ventricular outflow tract. Management Given the substantial risk of a third redo surgery and presence of very dilated RV with mechanical tricuspid valve, which prohibited maneuvering during the valve propagation, he was evaluated as unsuitable for transcatheter pulmonary valve implantation (PVI), and the multidisciplinary team opted for a hybrid perventricular approach. Procedural Technique The procedure was performed under general anesthesia in the hybrid catheter room. A left anterior mini-thoracotomy of approximately 10 cm was performed to expose the RV anterior wall. Two purse-string stitches with pledgets were placed on the RV anterior wall. An 18-gauge needle was used to puncture the RV wall, and an 11-F introducer sheath was inserted into the RV (Figure 2). The introducer sheath was aligned toward the RVOT and a 6-F pigtail catheter was advanced into the distal right PA over a 0.035-inch hydrophilic guidewire. Fluoroscopic imaging was performed through the delivery sheath and pigtail catheter (Figure 3, Video 1). Then the guidewire was exchanged with a Back-Up Meier guidewire (Boston Scientific). Balloon interrogation was subsequently performed through the delivery sheath. In the 30°right anterior oblique–30°cranial position, the pulmonary annulus was measured as 27.5 mm, RVOT 29.5 mm, and distance between RVOT and bifurcation 57 mm. In the 90° lateral position, the pulmonary annulus was measured as 27 mm, RVOT 29.5 mm, distance between RVOT and bifurcation 53.7 mm, and the narrowest diameter 25 mm. The balloon interrogation test was performed with an Amplatzer 34-mm sizing balloon (Abbott). Complete RVOT occlusion during balloon inflation confirmed adequate circumferential apposition and suitability for PVI (Figure 4, Video 2). Coronary compression test with a 6-F JL4 catheter was negative (Figure 5, Video 3). The sheath in the RV was exchanged with a 24-F Braidin Pro (APT Medical) delivery sheath. The Braidin Pro sheath was advanced to the RVOT through the guidewire. The Venus P-Valve 30/25 mm (Venus Medtech) and delivery system were advanced through the sheath until the proximal right PA and deployment was initiated gradually under fluoroscopic guidance. After partial expansion, the valve was gently retracted toward the main PA to achieve optimal positioning. Final release of the proximal segment was performed in a controlled fashion, ensuring appropriate alignment and stable anchoring within the RVOT (Figure 6, Video 4). Postimplant angiography confirmed an optimally positioned, functional pulmonary valve without regurgitation and obstruction (Figure 7, Video 5). An immediate and significant hemodynamic improvement was observed: the patient's aortic pressure increased from 98/58 (76) mm Hg preprocedure to 135/66 (95) mm Hg postprocedure. The sheath was removed, and the purse-string sutures were tightened. A 24-F drain was placed, and the chest was closed. Total procedural time was 100 minutes, and the time between the first diagnostic and final RV angiography was 45 minutes. The patient was extubated in the catheterization laboratory and warfarin was restarted the following day.Figure 2Hybrid Perventricular Access Via Left Mini-ThoracotomyIntraoperative photographs demonstrating surgical exposure of the right ventricular anterior wall through a left mini-thoracotomy, placement of purse-string sutures on the right ventricle, and direct introduction of the delivery sheath for perventricular valve implantation.Figure 3Angiographic Assessment of the RVOT and Main Pulmonary Artery During Hybrid Perventricular AccessFluoroscopic images demonstrating contrast injections into the RVOT and main pulmonary artery, performed through the 11-F introducer sheath in the first 2 panels and through a 6-F pigtail catheter advanced through the sheath in the last 2 panels, for pre-implantation anatomical assessment before valve deployment. Abbreviation as in Figure 1.Figure 4Balloon Interrogation of the RVOT Before Valve ImplantationFluoroscopic images demonstrating balloon sizing of the RVOT during contrast injection, confirming circumferential apposition and suitability for transcatheter valve implantation. (A) Right anterior oblique view, (B) Lateral view. Abbreviation as in Figure 1.Figure 5Coronary Compression Testing During Balloon InterrogationFluoroscopic images demonstrating simultaneous coronary angiography during balloon inflation within the right ventricular outflow tract to assess the risk of coronary artery compression before valve implantation. (A) Left anterior oblique (LAO) 40° with 30° caudal cranial/caudal tilt, (B) Lateral view.Figure 6Sequential Fluoroscopic Steps of Venus P-Valve ImplantationFluoroscopic images demonstrating the stepwise deployment of the Venus P-Valve: (A) advancement of the Braidin Pro delivery sheath into the right ventricular outflow tract; (B) positioning of the delivery sheath within the right pulmonary artery; (C-F) expansion of the distal and proximal flares; and (G, H) final positioning of the valve within the right ventricular outflow tract and main pulmonary artery.Figure 7Postimplantation Angiographic Assessment After Venus P-Valve DeploymentFluoroscopic images demonstrating contrast injections following Venus P-Valve implantation, confirming stable valve position within the right ventricular outflow tract and main pulmonary artery, with no residual pulmonary regurgitation or evidence of obstruction. (A) Right anterior oblique view, (B) Lateral view, (C) Posteroanterior view. Hybrid Perventricular Access Via Left Mini-Thoracotomy Intraoperative photographs demonstrating surgical exposure of the right ventricular anterior wall through a left mini-thoracotomy, placement of purse-string sutures on the right ventricle, and direct introduction of the delivery sheath for perventricular valve implantation. Angiographic Assessment of the RVOT and Main Pulmonary Artery During Hybrid Perventricular Access Fluoroscopic images demonstrating contrast injections into the RVOT and main pulmonary artery, performed through the 11-F introducer sheath in the first 2 panels and through a 6-F pigtail catheter advanced through the sheath in the last 2 panels, for pre-implantation anatomical assessment before valve deployment. Abbreviation as in Figure 1. Balloon Interrogation of the RVOT Before Valve Implantation Fluoroscopic images demonstrating balloon sizing of the RVOT during contrast injection, confirming circumferential apposition and suitability for transcatheter valve implantation. (A) Right anterior oblique view, (B) Lateral view. Abbreviation as in Figure 1. Coronary Compression Testing During Balloon Interrogation Fluoroscopic images demonstrating simultaneous coronary angiography during balloon inflation within the right ventricular outflow tract to assess the risk of coronary artery compression before valve implantation. (A) Left anterior oblique (LAO) 40° with 30° caudal cranial/caudal tilt, (B) Lateral view. Sequential Fluoroscopic Steps of Venus P-Valve Implantation Fluoroscopic images demonstrating the stepwise deployment of the Venus P-Valve: (A) advancement of the Braidin Pro delivery sheath into the right ventricular outflow tract; (B) positioning of the delivery sheath within the right pulmonary artery; (C-F) expansion of the distal and proximal flares; and (G, H) final positioning of the valve within the right ventricular outflow tract and main pulmonary artery. Postimplantation Angiographic Assessment After Venus P-Valve Deployment Fluoroscopic images demonstrating contrast injections following Venus P-Valve implantation, confirming stable valve position within the right ventricular outflow tract and main pulmonary artery, with no residual pulmonary regurgitation or evidence of obstruction. (A) Right anterior oblique view, (B) Lateral view, (C) Posteroanterior view. Outcome and Follow-Up At 30-day follow-up, the patient remained clinically stable. Echocardiography demonstrated a well-positioned pulmonary valve with no residual regurgitation or obstruction and preserved function of the preexisting mechanical prostheses. No arrhythmic, thrombotic, bleeding, or infective complication was observed. Discussion Chronic severe PR, a frequent sequela in patients with repaired RVOT dysfunction, leads to RV dilatation, which predisposes patients to right heart failure, arrhythmias, and even sudden cardiac death. Nearly all these patients require recurrent PVI later in life.1 PVI can be performed either through surgery or a transcatheter route. Although transcatheter PVI is the preferred less-invasive treatment, it may be limited by unfavorable anatomy or difficult vascular access.2 A hybrid approach may be considered in individuals with multiple prior sternotomies, prohibitive surgical risk, or anatomy unsuitable for transcatheter PVI.3 Several critical advantages of the hybrid ventricular approach for complex “redo” scenarios are highlighted by this case. First, the use of a left mini-thoracotomy provided a direct path to the RVOT, which was essential to protect the existing mechanical tricuspid valve. Navigating a 24-F delivery system through a mechanical prosthesis is technically prohibitive and carries a considerable risk of valvular damage or delivery system entrapment. Second, the advantage of performing the procedure "off-pump" on a beating heart was vital for this high-risk patient. Avoiding cardiopulmonary bypass significantly reduces systemic inflammatory response, blood product requirements, and myocardial injury, which are major concerns in redo-sternotomy cases. Hybrid PVI has been previously reported using various valve types, including balloon-expandable and other self-expanding systems.4,5 Hybrid PVI cases primarily aim to surgically plicate an aneurysmal or excessively large RVOT, thereby reducing its diameter to make it suitable for standard transcatheter PVI. Another group requiring the hybrid approach includes patients with limited venous access. Although both strategies have been successfully implemented using balloon-expandable valves, the existing literature regarding the Venus P-Valve in hybrid procedures is extremely limited.6, 7, 8, 9 The Venus P-Valve was particularly suited for this patient's anatomy. Its flared, double-dumbbell design provides superior anchoring in native or patched RVOTs where balloon-expandable valves might lack stability. Pre-implant computed tomography planning demonstrated an hour-glass RVOT/main pulmonary artery (MPA) configuration with sinotubular junction folding. This segment was interpreted as supportive but potentially expandable rather than the sole anchoring site. Overall computed tomography assessment suggested limited distensibility of the RVOT/MPA complex, favoring a transannular implantation strategy. In view of the sinotubular narrowing and the limited distensibility of the RVOT/MPA complex, a 30/25-mm Venus P-Valve was selected without significant oversizing. Final device selection was then refined by invasive angiography and balloon interrogation, which confirmed suitable apposition and no coronary compression. The immediate rise in systemic aortic pressure after implantation is a noteworthy finding. This hemodynamic response was considered most likely related to the acute elimination of severe PR, with reduction in RV volume overload, improvement in effective forward pulmonary blood flow, and increased left ventricular preload and systemic output. A limitation of this case is the absence of cardiac MRI-derived RV volumetric and PR fraction data. However, the patient was symptomatic and echocardiographic findings consistent with severe PR, which were considered sufficient to support the indication for PVI. To the best of our knowledge, this is the first case report describing the successful implantation of a Venus P-Valve via a direct perventricular approach without RVOT plication, expanding the therapeutic options for patients in whom transvenous access is precluded by mechanical prostheses. This case highlights the multidisciplinary approach, in which surgical access skills and interventional precision are merged to provide a solution for a patient who might otherwise be considered for redo surgery.10 Conclusions Hybrid perventricular Venus P-Valve implantation via mini-thoracotomy is a safe and effective strategy in selected patients with severe PR and a mechanical tricuspid prosthesis that precludes standard transvenous access. This approach minimizes procedural risk by avoiding cardiopulmonary bypass and redo sternotomy while achieving excellent hemodynamic outcomes and facilitating rapid recovery.Take-Home Messages•Hybrid perventricular access may provide a transcatheter treatment option when a mechanical tricuspid prosthesis makes conventional transvenous delivery unsafe or technically prohibitive.•Careful computed tomography angiography assessment, balloon interrogation, and coronary compression testing are essential for procedural planning. Take-Home Messages •Hybrid perventricular access may provide a transcatheter treatment option when a mechanical tricuspid prosthesis makes conventional transvenous delivery unsafe or technically prohibitive.•Careful computed tomography angiography assessment, balloon interrogation, and coronary compression testing are essential for procedural planning. •Hybrid perventricular access may provide a transcatheter treatment option when a mechanical tricuspid prosthesis makes conventional transvenous delivery unsafe or technically prohibitive. Hybrid perventricular access may provide a transcatheter treatment option when a mechanical tricuspid prosthesis makes conventional transvenous delivery unsafe or technically prohibitive. •Careful computed tomography angiography assessment, balloon interrogation, and coronary compression testing are essential for procedural planning. Careful computed tomography angiography assessment, balloon interrogation, and coronary compression testing are essential for procedural planning. Funding Support and Author Disclosures Prof Alper Guzeltas is a proctor for Venus Medtech. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.